R&D News - Pharmaceutical Executive


R&D News
Corporate strategies and tactics for more effective drug development.

Lilly's New Blood Thinner No Blockbuster

November 6, 2007

Safety Risks, Generic Threat Scale Down Big Hopes

Genzyme Forms Partnership with Overseas Gene Therapy Company

October 31, 2007

Genzyme will collaborate with Chinese biotech manufacturer Sunway to perform clinical trials and potentially produce the experimental gene therapy HIF-1a in China.

Eli Lilly Quietly Suspends Two Trials

October 31, 2007

The company halts two small pharmacodynamic trials of a key candidate just days before a major presentation of data. Is something wrong with prasugrel? And why is Lilly playing the news so close to the chest?

Medtronic Wins Recommendation for Safer Drug-Eluting Stents

October 17, 2007

FDA advisory panel notes high efficacy—and no thrombosis after six months—in clinical trials. Nonetheless, Medtronic's stents will be under close postapproval watch.

BMS Snags Biotech Firm Adnexus

October 3, 2007

Adnexus' protein-building technology could spell new drugs and big profits for BMS--if the drug development engine works.

GSK Boosts Flu Doses

September 19, 2007

Drug company increases vaccine supply by 10 million in advance of influenza season

New Rules for Asthma-Med Makers

September 6, 2007

NHLBI releases updated regulations for asthma treatment

Glaxo Gives High-Five to Cancer Market

June 27, 2007

Big crop of oncology drugs is the fruit of Garnier's excellent restructuring

Global Access for Pfizer's New HIV Drug

June 20, 2007

Maraviroc's promise shows the value of expanded-access programs


Click here